NCT00195195View on ClinicalTrials.gov

Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Transplantation
Interventions
DRUG

Sirolimus

Transplantation patients treated with sirolimus who consent to participate in the study (register)

Trial Locations (3)

SE-413 45

Gothenburg

SE-141 86

Stockholm

SE-751 85

Uppsala

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195195 - Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries | Biotech Hunter | Biotech Hunter